Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Crossflo terms of merger
Reply New Message
Back To Forum List View
Icon president Crossflo terms of merger

l2007s
Feb 09, 2011 06:57PM

of 2,844,630 shares of our common stock (“Escrow Shares”) be deposited with a third party escrow agent. Per the Escrow Agreement, one year following the closing date.

So I guess that accounts for that number of shares, what about the other shares?

Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply